Hypogonadism Completed Phase 2 Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00104572Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.Treatment
NCT00179517Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or PlaceboTreatment
NCT00136695Anastrozole Administration in Elderly Hypogonadal MenTreatment